decreased length of allograft survival_Tnfrsf14<tm1Wwhk>/Tnfrsf14<tm1Wwhk>

http://metadb.riken.jp/0004752B6CgTnfrsf14tm1WwhkTnfrsf14tm1WwhkTnfrsf14tm1WwhkTnfrsf14tm1Wwhk

decreased length of allograft survival_Tnfrsf14<tm1Wwhk>/Tnfrsf14<tm1Wwhk>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)
  http://metadb.riken.jp/db/mgi_rdf/MGI:2675303

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tnfrsf14<tm1Wwhk>/Tnfrsf14<tm1Wwhk>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tnfrsf14<tm1Wwhk>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.Cg-Tnfrsf14<tm1Wwhk>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased length of allograft survival
  http://purl.obolibrary.org/obo/MP_0004752

文献

http://purl.org/net/cito/citesAsAuthority

• Ran. Tao, et.al., Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts., Journal of immunology (Baltimore, Md. : 1950), 2005, 175
  http://rdf.ncbi.nlm.nih.gov/pubmed/16237069